Back close

Modulation of fibrino(geno)lytic proteases from Russell’s viper venom using natural products and analogs

Start Date: Wednesday, Dec 01,2010

School: School of Biotechnology

Project Incharge:Dr. Martin Reick
Funded by:Amrita Vishwa Vidyapeetham
Modulation of fibrino(geno)lytic proteases from Russell’s viper venom using natural products and analogs

Envenomation incapacitates the snake’s prey by interfering with specific aspects of physiological function such as nerve transmission and hemostasis.  Since the action of venom components is highly specific, many venom components may also have the potential of being employed pharmaceutically. Viper venom affects predominantly aspects of the coagulation pathway.  The conversion of fibrinogen to fibrin is a central part of the coagulation and clotting mechanism and hence another project in the lab is focusing on the isolation of proteases capable of altering or degrading fibrinogen and on the modulation of their proteolytic activity by small molecules and phytochemicals. 

Related Projects

Enhancement of Biodegradative Activity in Commercial and Lab Scale Compost Preparations with Lignocelluloytic fungi and nitrogen fixing bacteria as supplements- A Comparative Study
Enhancement of Biodegradative Activity in Commercial and Lab Scale Compost Preparations with Lignocelluloytic fungi and nitrogen fixing bacteria as supplements- A Comparative Study
Construction of a Prototype of Microbial Fuel Cell
Construction of a Prototype of Microbial Fuel Cell
Modelling the cerebellar information code in large-scale realistic circuits – Towards pharmacological predictions and robotic abstractions
Modelling the cerebellar information code in large-scale realistic circuits – Towards pharmacological predictions and robotic abstractions
Screening of Dietary Substances: New Blockade Strategy on Quorum Sensing
Screening of Dietary Substances: New Blockade Strategy on Quorum Sensing
Paraptosis: a non-apoptotic cell death pathway to target cancer
Paraptosis: a non-apoptotic cell death pathway to target cancer
Admissions Apply Now